PT - JOURNAL ARTICLE AU - Thomas Müller AU - Insha Rasool AU - Peter Heinz-Erian AU - Eva Mildenberger AU - Christian Hülstrunk AU - Andreas Müller AU - Laurent Michaud AU - Bart G P Koot AU - Antje Ballauff AU - Julia Vodopiutz AU - Stefan Rosipal AU - Britt-Sabina Petersen AU - Andre Franke AU - Irene Fuchs AU - Heiko Witt AU - Heinz Zoller AU - Andreas R Janecke AU - Sandhya S Visweswariah TI - Congenital secretory diarrhoea caused by activating germline mutations in <em>GUCY2C</em> AID - 10.1136/gutjnl-2015-309441 DP - 2016 Aug 01 TA - Gut PG - 1306--1313 VI - 65 IP - 8 4099 - http://gut.bmj.com/content/65/8/1306.short 4100 - http://gut.bmj.com/content/65/8/1306.full SO - Gut2016 Aug 01; 65 AB - Objective Congenital sodium diarrhoea (CSD) refers to a form of secretory diarrhoea with intrauterine onset and high faecal losses of sodium without congenital malformations. The molecular basis for CSD remains unknown. We clinically characterised a cohort of infants with CSD and set out to identify disease-causing mutations by genome-wide genetic testing.Design We performed whole-exome sequencing and chromosomal microarray analyses in 4 unrelated patients, followed by confirmatory Sanger sequencing of the likely disease-causing mutations in patients and in their family members, followed by functional studies.Results We identified novel de novo missense mutations in GUCY2C, the gene encoding receptor guanylate cyclase C (GC-C) in 4 patients with CSD. One patient developed severe, early-onset IBD and chronic arthritis at 4 years of age. GC-C is an intestinal brush border membrane-bound guanylate cyclase, which functions as receptor for guanylin, uroguanylin and Escherichia coli heat-stable enterotoxin. Mutations in GUCY2C were present in different intracellular domains of GC-C, and were activating mutations that enhanced intracellular cyclic guanosine monophosphate accumulation in a ligand-independent and ligand-stimulated manner, following heterologous expression in HEK293T cells.Conclusions Dominant gain-of-function GUCY2C mutations lead to elevated intracellular cyclic guanosine monophosphate levels and could explain the chronic diarrhoea as a result of decreased intestinal sodium and water absorption and increased chloride secretion. Thus, mutations in GUCY2C indicate a role for this receptor in the pathogenesis of sporadic CSD.